Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Eli Lilly Adds Jobs, Plans Cuts
WSJ Online
Thursday, October 22, 2009 - 4:15pm
tags:
Eli Lilly, layoffs, reorganization
Novartis CEO Says Most U.S. Swine Flu Vaccine Coming Next Year
Bloomberg
Thursday, October 22, 2009 - 4:14pm
tags:
Novartis, H1N1, swine flu, vaccines, Daniel Vasella
Drug stocks wrap around flat line; Amgen falls on drug delay
Marketwatch
Thursday, October 22, 2009 - 4:13pm
tags:
drug stocks, Amgen, FDA
Bio Box: Eli Lilly CEO John Lechleiter
Yahoo/AP
Thursday, October 22, 2009 - 4:11pm
tags:
Pharma CEOs, Eli Lilly, John Lechleiter
Novartis' Tasigna Seen Succeeding Top Drug Gleevec
WSJ Online
Thursday, October 22, 2009 - 9:48am
tags:
Novartis, Tasigna, Gleevac, leukemia
Red Flags in Biotech
In the Pipeline
Thursday, October 22, 2009 - 9:45am
tags:
biotech
C.R. Bard Surpasses Zacks Estimate
Yahoo/Zacks.com
Thursday, October 22, 2009 - 9:43am
tags:
CR Bard, earnings
Mixed data for AZ, BMS diabetes drug in new study
Reuters
Thursday, October 22, 2009 - 9:24am
tags:
Bristol-Myers Squibb, diabetes, AstraZeneca, Dapagliflozin
Earnings Call Is a Requiem for Schering-Plough
WSJ Online
Thursday, October 22, 2009 - 9:21am
tags:
earnings, Schering Plough
Schering-Plough Discriminated Against Some Docs?
Pharmalot
Thursday, October 22, 2009 - 9:19am
tags:
Schering Plough, physician gifts
FDA delays ruling on Acorda's MS drug until Jan. 22
Yahoo/AP
Thursday, October 22, 2009 - 9:13am
tags:
Acorda Therapeutics, FDA, MS, multiple sclerosis, Fampridine-SR
Celgene earnings rise in quarter
Marketwatch
Thursday, October 22, 2009 - 9:13am
tags:
Celgene, earnings
Pick Up Antigenics at a Bargain Price
Seeking Alpha
Thursday, October 22, 2009 - 9:11am
tags:
Antigenics, Oncophage
Teva seeking to sell generic version of Cephalon’s Nuvigil sleep disorder drug
Bizjournals.com
Thursday, October 22, 2009 - 9:10am
tags:
Cephalon, NUVIGIL, Teva Pharmaceuticals, generics
Novartis Faces A Trial In Sex Discrimination Lawsuit Filed By Female Sales Reps
Pharmalot
Thursday, October 22, 2009 - 9:07am
tags:
discrimination, Novartis, lawsuits
Pfizer Won't Share Wyeth's Q3 Numbers; Layoff Announcements Due This Week
BNET Pharma
Thursday, October 22, 2009 - 9:05am
tags:
Pfizer, Wyeth, M&A, layoffs, reorganization
Bristol-Myers’ Profit Rises, Tops Analyst Estimates
Bloomberg
Thursday, October 22, 2009 - 9:04am
tags:
Bristol-Myers Squibb, earnings
GE, Lilly Develop Test to Improve Cancer Treatments
Bloomberg
Thursday, October 22, 2009 - 9:03am
tags:
cancer, Eli Lilly, GE, drug development
Merck's quarterly net profit triples on asset sale
Marketwatch
Thursday, October 22, 2009 - 8:58am
tags:
Merck, earnings
Schering-Plough net income falls 17%
Marketwatch
Thursday, October 22, 2009 - 7:03am
tags:
Schering Plough, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.